131 related articles for article (PubMed ID: 17652890)
1. Efficacy and safety of the additional bepridil treatment in patients with atrial fibrillation refractory to class I antiarrhythmic drugs.
Miyaji K; Tada H; Fukushima Kusano K; Hashimoto T; Kaseno K; Hiramatsu S; Tadokoro K; Naito S; Nakamura K; Oshima S; Taniguchi K; Ohe T
Circ J; 2007 Aug; 71(8):1250-7. PubMed ID: 17652890
[TBL] [Abstract][Full Text] [Related]
2. Use of bepridil in combination with Ic antiarrhythmic agent in converting persistent atrial fibrillation to sinus rhythm.
Imai S; Saito F; Takase H; Enomoto M; Aoyama H; Yamaji S; Yokoyama K; Yagi H; Kushiro T; Hirayama A
Circ J; 2008 May; 72(5):709-15. PubMed ID: 18441448
[TBL] [Abstract][Full Text] [Related]
3. Conversion and maintenance of sinus rhythm by bepridil in patients with persistent atrial fibrillation.
Nakazato Y; Yasuda M; Sasaki A; Iida Y; Kawano Y; Nakazato K; Tokano T; Mineda Y; Sumiyoshi M; Nakata Y; Daida H
Circ J; 2005 Jan; 69(1):44-8. PubMed ID: 15635201
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome in patients with paroxysmal or persistent atrial fibrillation receiving bepridil.
Shiga T; Suzuki A; Naganuma M; Hosaka F; Shoda M; Hagiwara N
Circ J; 2011; 75(6):1334-42. PubMed ID: 21483159
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of amiodarone versus bepridil in achieving conversion to sinus rhythm in patients with persistent atrial fibrillation: a randomised trial.
Yamase M; Nakazato Y; Daida H
Heart; 2012 Jul; 98(14):1067-71. PubMed ID: 22689712
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological cardioversion of persistent atrial fibrillation with and without a history of drug-resistant paroxysmal atrial fibrillation.
Fujiki A; Sakamoto T; Iwamoto J; Nishida K; Nagasawa H; Mizumaki K; Inoue H
Circ J; 2006 Sep; 70(9):1138-41. PubMed ID: 16936425
[TBL] [Abstract][Full Text] [Related]
7. Beta-blocker decreases the increase in QT dispersion and transmural dispersion of repolarization induced by bepridil.
Yoshiga Y; Shimizu A; Yamagata T; Hayano T; Ueyama T; Ohmura M; Itagaki K; Kimura M; Matsuzaki M
Circ J; 2002 Nov; 66(11):1024-8. PubMed ID: 12419934
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effect of bepridil on paroxysmal atrial fibrillation: relationship between efficacy and the f-f interval in surface ECG recordings.
Yoshida T; Niwano S; Inuo K; Saito J; Kojima J; Ikeda-Murakami K; Hara H; Izumi T
Circ J; 2003 Jan; 67(1):11-5. PubMed ID: 12520144
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of sinus rhythm and recovery of atrial mechanical function after cardioversion with bepridil or in combination with aprindine in long-lasting persistent atrial fibrillation.
Fujiki A; Tsuneda T; Sakabe M; Nakagawa K; Mizumaki K; Hirai T; Inoue H
Circ J; 2004 Sep; 68(9):834-9. PubMed ID: 15329504
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced changes in fibrillation cycle length and organization index can predict chemical cardioversion of long-lasting atrial fibrillation with bepridil alone or in combination with aprindine.
Fujiki A; Sakabe M; Nishida K; Sugao M; Tsuneda T; Iwamoto J; Mizumaki K; Inoue H
Circ J; 2004 Dec; 68(12):1139-45. PubMed ID: 15564697
[TBL] [Abstract][Full Text] [Related]
11. Usefulness and safety of bepridil in converting persistent atrial fibrillation to sinus rhythm.
Fujiki A; Tsuneda T; Sugao M; Mizumaki K; Inoue H
Am J Cardiol; 2003 Aug; 92(4):472-5. PubMed ID: 12914884
[TBL] [Abstract][Full Text] [Related]
12. Bepridil is effective and improves QOL in multidrug-resistant paroxysmal atrial fibrillation.
Shamoto A; Chishaki A; Tsuchihashi-Makaya M; Chishaki H; Takemoto M; Mukai Y; Inoue S; Sunagawa K
J Cardiovasc Med (Hagerstown); 2012 Nov; 13(11):747-54. PubMed ID: 22914308
[TBL] [Abstract][Full Text] [Related]
13. Time-Dependent Changes in QT Dynamics after Initiation and Termination of Paroxysmal Atrial Fibrillation.
Yamaguchi Y; Mizumaki K; Nishida K; Sakamoto T; Kataoka N; Nakatani Y; Inoue H
Pacing Clin Electrophysiol; 2015 Dec; 38(12):1418-24. PubMed ID: 26391623
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol is effective and safe in combination with bepridil for persistent atrial fibrillation and decreases the QT prolongation induced by bepridil therapy.
Kawamura M; Munetsugu Y; Tanno K; Kobayashi Y
J Cardiovasc Pharmacol; 2013 Jan; 61(1):77-82. PubMed ID: 23107870
[TBL] [Abstract][Full Text] [Related]
15. Dose-response effects of bepridil in patients with persistent atrial fibrillation monitored with transtelephonic electrocardiograms: a multicenter, randomized, placebo-controlled,double-blind study (J-BAF Study).
Yamashita T; Ogawa S; Sato T; Aizawa Y; Atarashi H; Fujiki A; Inoue H; Ito M; Katoh T; Kobayashi Y; Koretsune Y; Kumagai K; Niwano S; Okazaki O; Okumura K; Saku K; Tanabe T; Origasa H;
Circ J; 2009 Jun; 73(6):1020-7. PubMed ID: 19359813
[TBL] [Abstract][Full Text] [Related]
16. Contributing factors to the apparent clearance of bepridil in patients with paroxysmal or persistent atrial fibrillation: analysis using population pharmacokinetics.
Shiga T; Hashiguchi M; Naganuma M; Suzuki A; Hagiwara N
Ther Drug Monit; 2013 Jun; 35(3):367-73. PubMed ID: 23666576
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of adverse effects during bepridil administration for atrial fibrillation and flutter.
Yasuda M; Nakazato Y; Sasaki A; Kawano Y; Nakazato K; Tokano T; Daida H
Circ J; 2006 Jun; 70(6):662-6. PubMed ID: 16723784
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological cardioversion of long-lasting atrial fibrillation.
Fujiki A; Inoue H
Circ J; 2007; 71 Suppl A():A69-74. PubMed ID: 17587743
[TBL] [Abstract][Full Text] [Related]
19. Impact of postprocedural antiarrhythmic drug therapy with bepridil on maintaining sinus rhythm after catheter ablation for persistent atrial fibrillation.
Kondo T; Miake J; Kato M; Ogura K; Iitsuka K; Yamamoto K
J Cardiol; 2016 Sep; 68(3):229-35. PubMed ID: 26654806
[TBL] [Abstract][Full Text] [Related]
20. Repetitive evaluation of fibrillation cycle length predicts the efficacy of bepridil for interruption of long-lasting persistent atrial fibrillation.
Aoyama Y; Niwano S; Niwano H; Satoh A; Kishihara J; Ishikawa S; Murakami M; Fukumoto K; Ueno K; Izumi T
Int Heart J; 2011; 52(6):353-8. PubMed ID: 22188708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
